HYREQ — HC Liquidating Income Statement
0.000.00%
FinancialsHighly SpeculativeMicro Cap
- $0.00m
- -$8.61m
- $35.72m
Annual income statement for HC Liquidating, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3.22 | 9.78 | 15.9 | 25.2 | 35.7 |
Cost of Revenue | |||||
Gross Profit | 0.311 | 4.64 | 6.01 | 8.27 | 9.77 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 7.29 | 18.9 | 28.5 | 40.5 | 61.7 |
Operating Profit | -4.07 | -9.16 | -12.7 | -15.3 | -26 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -4.27 | -11.2 | -12.5 | -15.2 | -26 |
Provision for Income Taxes | |||||
Net Income After Taxes | -4.27 | -11.2 | -12.5 | -15.2 | -26 |
Net Income Before Extraordinary Items | |||||
Net Income | -4.27 | -11.2 | -12.5 | -15.2 | -26 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -4.27 | -11.2 | -12.5 | -15.2 | -26 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.425 | -1.31 | -0.897 | -0.867 | -1.32 |
Dividends per Share |